PELP1 and ovarian carcinoma: Some of the gene-to-gene mRNA expression levels interactions are changed in benign malignancies and aberrant in ovarian cancer, especially regarding PELP1. The deregulation of estrogen signaling pathway seems to be the key factor associated with ovarian cancer pathology.